Literature DB >> 1900367

Expression of the amyloid precursor protein gene in mouse oocytes and embryos.

S Fisher1, J D Gearhart, M L Oster-Granite.   

Abstract

The amyloid precursor protein (APP) is thought to be processed aberrantly to yield the major constituent of the amyloid plaques observed in the brains of patients with Alzheimer disease and Down syndrome. However, the gene encoding APP is expressed widely in normal human tissues and in adult and fetal mouse tissues and is alternatively spliced in a tissue-specific pattern in the adult. There is evidence that APP may function as a growth factor and as a mediator of cell adhesion and in these roles could be important in morphogenesis. As a step toward determining the role of APP in development and in determining how the adult pattern of tissue-specific splicing is established, we have used reverse transcription and the polymerase chain reaction to demonstrate APP expression in mouse oocytes, preimplantation embryos, and postimplantation embryonic stages to the late embryonic period. All three splicing forms described in mouse were present at each stage, although there were changes in the ratios of the splicing forms at different stages. Screens for APP clones in embryonic cDNA libraries from the egg cylinder stage and the early somite stage were used to confirm the results of the polymerase chain reaction, and APP clone abundance was found to increase 10-fold between the two stages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900367      PMCID: PMC51108          DOI: 10.1073/pnas.88.5.1779

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Developmental expression of the amyloid precursor protein, growth-associated protein 43, and somatostatin in normal and trisomy 16 mice.

Authors:  B F O'Hara; S Fisher; M L Oster-Granite; J D Gearhart; R H Reeves
Journal:  Brain Res Dev Brain Res       Date:  1989-10-01

2.  Expression of the Alzheimer amyloid precursor gene transcripts in the human brain.

Authors:  R L Neve; E A Finch; L R Dawes
Journal:  Neuron       Date:  1988-10       Impact factor: 17.173

3.  Quantitative changes in total RNA, total poly(A), and ribosomes in early mouse embryos.

Authors:  L Pikó; K B Clegg
Journal:  Dev Biol       Date:  1982-02       Impact factor: 3.582

4.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  Polyadenylated RNA of mouse ova and loss of maternal RNA in early development.

Authors:  R Bachvarova; V De Leon
Journal:  Dev Biol       Date:  1980-01       Impact factor: 3.582

7.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

8.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.

Authors:  R E Tanzi; A I McClatchey; E D Lamperti; L Villa-Komaroff; J F Gusella; R L Neve
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

9.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.

Authors:  P Ponte; P Gonzalez-DeWhitt; J Schilling; J Miller; D Hsu; B Greenberg; K Davis; W Wallace; I Lieberburg; F Fuller
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

10.  Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development.

Authors:  C A Brenner; R R Adler; D A Rappolee; R A Pedersen; Z Werb
Journal:  Genes Dev       Date:  1989-06       Impact factor: 11.361

View more
  12 in total

1.  Repression of the beta-amyloid gene in a Hox-3.1-producing cell line.

Authors:  S M Violette; C S Shashikant; J M Salbaum; H G Belting; J C Wang; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 2.  A TAG on to the neurogenic functions of APP.

Authors:  Quan-Hong Ma; Dominique Bagnard; Zhi-Cheng Xiao; Gavin S Dawe
Journal:  Cell Adh Migr       Date:  2008-01-25       Impact factor: 3.405

Review 3.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

4.  Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex.

Authors:  L J Martin; C A Pardo; L C Cork; D L Price
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

5.  Identification of sexually dimorphic gene expression in brain tissue of the fish Leporinus macrocephalus through mRNA differential display and real time PCR analyses.

Authors:  Fernanda A Alves-Costa; A P Wasko
Journal:  Genetica       Date:  2009-11-05       Impact factor: 1.082

6.  Amyloid precursor protein is a restriction factor that protects against Zika virus infection in mammalian brains.

Authors:  Amy Lingel; Haishuang Lin; Yuval Gavriel; Eric Weaver; Pascal Polepole; Virginia Lopez; Yuguo Lei; Thomas M Petro; Beka Solomon; Chi Zhang; Luwen Zhang
Journal:  J Biol Chem       Date:  2020-10-07       Impact factor: 5.157

7.  Expression of the human beta-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice.

Authors:  B E Pearson; T K Choi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

8.  Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome.

Authors:  D M Holtzman; R M Bayney; Y W Li; H Khosrovi; C N Berger; C J Epstein; W C Mobley
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

9.  Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-β production in human neuron-like cells.

Authors:  Elina M Sutinen; Tuula Pirttilä; George Anderson; Antero Salminen; Johanna O Ojala
Journal:  J Neuroinflammation       Date:  2012-08-16       Impact factor: 8.322

10.  The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events.

Authors:  Kiran Bhaskar; Megan Miller; Alexandra Chludzinski; Karl Herrup; Michael Zagorski; Bruce T Lamb
Journal:  Mol Neurodegener       Date:  2009-03-16       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.